Bausch Health Co. Inc. (BHC) Q3 Revenue Tops Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Bausch Health Co. Inc. (BHC) Q3 Revenue Tops Views

Bausch Health Co. Inc. (BHC) Reports U.S. Launch of BRYHALI (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis in Adults

November 7, 2018 7:23 AM EST

Bausch Health Companies Inc. (NYSE: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced it expects to start distribution of BRYHALI (halobetsasol propionate) Lotion, 0.01%, to U.S. wholesale pharmaceutical distributors later this month. The company received final approval from the U.S. Food and Drug Administration (FDA) for BRYHALI Lotion on Nov. 6, 2018. BRYHALI Lotion, which is indicated for the topical treatment of plaque psoriasis in adult patients, is a new potent to superpotent corticosteroid in a novel vehicle lotion with safety established for... More

Bausch Health Companies (BHC) PT Raised to $31 at RBC Capital

November 7, 2018 7:10 AM EST

RBC Capital analyst Doug Miehm raised the price target on Bausch Health Companies (NYSE: BHC) to $31.00 (from $30.00) while maintaining a Sector Perform rating.

... More